The Journal of Neuroscience, August 27, 2003, 23(21):7881-7888
Previous Article | Next Article 
Glutamate Decreases Mitochondrial Size and Movement in Primary Forebrain Neurons
Gordon L. Rintoul,
Anthony J. Filiano,
Jacques B. Brocard,
Geraldine J. Kress, and
Ian J. Reynolds
Department of Pharmacology, University of Pittsburgh, Pittsburgh,
Pennsylvania 15261
 |
Abstract
|
|---|
Mitochondria are essential to maintain neuronal viability. In addition to
the generation of ATP and maintenance of calcium homeostasis, the effective
delivery of mitochondria to the appropriate location within neurons is also
likely to influence their function. In this study we examined mitochondrial
movement and morphology in primary cultures of rat forebrain using a
mitochondrially targeted enhanced yellow fluorescent protein (mt-eYFP).
Mt-eYFP-labeled mitochondria display a characteristic elongated phenotype and
also move extensively. Application of glutamate to cultures results in a rapid
diminution of movement and also an alteration from elongated to rounded
morphology. This effect required the entry of calcium and was mediated by
activation of the NMDA subtype of glutamate receptor. Treatment of cultures
with an uncoupler or blocking ATP synthesis with oligomycin also stopped
movement but did not alter morphology. Interestingly, application of glutamate
together with the uncoupler did not prevent the changes in movement or shape
but facilitated recovery after washout of the stimuli. This suggests that the
critical target for calcium in this paradigm is cytosolic. These studies
demonstrate that in addition to altering the bioenergetic properties of
mitochondria, neurotoxins can also alter mitochondrial movement and
morphology. We speculate that neurotoxin-mediated impairment of mitochondrial
delivery may contribute to the injurious effects of neurotoxins.
Key words: green fluorescent protein; cytoskeleton; NMDA receptor; intracellular calcium; excitotoxicity; organelle transport
 |
Introduction
|
|---|
It is widely appreciated that mitochondria in neurons are the target of a
number of neurotoxins. These include agents such as rotenone,
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and 3-nitroproprionic
acid, and perhaps zinc, that impair mitochondrial electron transport and
probably kill neurons by a combination of ATP depletion and excessive
generation of reactive oxygen species (ROS)
(Heales et al., 1999
;
Schapira, 1999
;
Beal, 2000
;
Weiss et al., 2000
).
Mitochondria also represent an important target in NMDA receptor-mediated
excitotoxic neuronal injury. In this case, excessive calcium entry results in
substantial mitochondrial calcium accumulation, mitochondrial depolarization,
ROS generation, and, ultimately, cell death
(Dugan et al., 1995
;
Reynolds and Hastings, 1995
;
White and Reynolds, 1995
,
1996
;
Schinder et al., 1996
;
Nicholls and Budd, 2000
). The
neurotoxic effects of NMDA receptor activation can be occluded by prevention
of mitochondrial calcium accumulation, suggesting that mitochondria are one of
the critical targets of cellular calcium overload
(Budd and Nicholls, 1996
;
Stout et al., 1998
).
Studies on the role of mitochondria in neuronal injury have generally
focused on the bioenergetic consequences of mitochondrial impairment; however,
there are several important dynamics to consider that extend beyond the
capacity of mitochondria to generate ATP and ROS. Mitochondria are
semi-autonomous organelles that are capable of replicating their own genome,
synthesizing proteins, and undergoing fission and fusion, and presumably
degradation too (for review, see
Scheffler, 1999
). It is widely
believed (although not necessarily proven) that new mitochondria are generated
near the nucleus (Davis and Clayton,
1996
), where they can import the large cohort of nuclear-encoded,
mitochondrially targeted proteins
(Scheffler, 1999
).
Mitochondria are then transported to appropriate cellular locations
(Morris and Hollenbeck, 1993
;
Ligon and Steward, 2000a
)
that, in the case of neurons, may be a substantial distance from the presumed
site of biogenesis at the cell soma. Alterations in mitochondrial distribution
and morphology have been associated with various disease states. Ebneth and
colleagues (1998
) reported
that overexpression of tau results in the failure of the cell to transport
mitochondria to peripheral cell compartments, which may be of relevance to
Alzheimer's disease. Alterations in mitochondrial transport and morphology
have also been associated with cancer
(Djaldetti, 1982
), liver
disease (Tandler and Hoppel,
1986
), and muscular dystrophy
(Nishino et al., 1998
).
It is becoming clear that mitochondrial morphology is a dynamic that can be
altered by a number of factors, including the induction of cell injury.
Mitochondrial fragmentation has been reported in cells stimulated to undergo
apoptosis, and prevention of fragmentation may be cytoprotective
(Jouaville et al., 1999
;
Frank et al., 2001
). Previous
studies have also suggested calcium-mediated alterations in mitochondrial
morphology in neurons and astrocytes
(Kristal and Dubinsky, 1997
;
Dubinsky and Levi, 1998
). In
the present study we have investigated characteristics of mitochondrial
movement and morphology in primary cultures of forebrain neurons transfected
with mitochondrially targeted fluorescent proteins. We have found that
mitochondrial depolarization inhibits movement of mitochondria in processes;
however, glutamate both inhibits movement and causes a profound remodeling of
mitochondria as the result of an action of calcium in the cytosol of neurons.
The rate of recovery of mitochondria from this insult is promoted when
mitochondrial calcium loading is prevented. These studies reveal a novel
aspect of glutamate-mediated injury to neurons and raise the possibility that
altered mitochondrial morphology or trafficking might contribute to neuronal
injury.
Some of these results have been published previously in abstract form
(Rintoul et al., 2002
).
 |
Materials and Methods
|
|---|
DNA constructs. The mitochondrially targeted eYFP construct
(generously provided by Dr. Roger Y. Tsien, University of California, San
Diego) consists of the gene for eYFP, inserted into the mammalian expression
vector pCDNA3 (Invitrogen). The recombinant protein is targeted to the
mitochondrial matrix using the targeting sequence from subunit IV of
cytochrome c oxidase (Llopis et
al., 1998
). All other fluorescent protein expression vectors were
purchased from Clontech. The cytosolic eCFP vector was constructed by excising
the enhanced cyan fluorescent protein (eCFP) gene from peCFP-mito with
BamHI and NotI. This fragment was then inserted into the
BamHI and NotI restriction sites of the pHcRed1-N1
expression vector (replacing the HcRed gene). All plasmids were amplified
using Qiagen Maxi- and Mega-prep kits according to the manufacturer's
instructions.
Transfection of cortical cultures. Experiments were performed on
dissociated primary cortical cultures, used between 12 and 19 d in
vitro. Details of the culturing technique have been described previously
(Kress et al., 2002
). At this
age in culture they are synaptically connected and vulnerable to excitotoxic
cell death. Neurons were transfected using a modified calcium phosphate
transfection technique (Xia et al.,
1996
). This typically results in transfection efficiencies of
1-2%. Neurons were imaged 2-3 d after transfection.
Analysis of mitochondrial movement. Data were acquired using an
acquisition system described previously
(Buckman and Reynolds, 2001
).
Simple PCI software (Compix, Inc., Cranberry PA) was used for data
acquisition. In all experiments we used a HEPES-buffered salt solution (HBSS)
of the following composition (in mM): 137 NaCl, 5 KCl, 10
NaHCO3, 20 HEPES, 5.5 glucose, 0.6 KH2PO4,
0.6. Na2HPO4, 1.4 CaCl2, and 0.9
MgSO4, adjusted to pH 7.4 with NaOH. In Ca2+-free
experiments, Ca2+ was omitted and the buffer was supplemented with
20 µM EGTA. All drugs used were purchased from Sigma (St. Louis,
MO). Working solutions were prepared in HBSS from the following stock
solutions: 10 mM glutamate in water, 10 mM glycine in
water, 750 µM
carbonylcyanide-p-(trifluoromethoxy)-phenylhydrazone (FCCP) in methanol, 10
mM kainate in water, and 10 mM NMDA in water. Cells were
perfused with 5 ml/min HBSS for the duration of each experiment, and the
chamber temperature was maintained at 37°C by heating the buffer.
Mitochondrial movement was detected by monitoring the fluorescence
intensity of individual pixels in digitized images of fields containing a
single transfected neuron. Twenty fluorescence digital images of a field were
collected over 2 min. A 255 x 255 pixel subfield containing neuronal
processes was selected for analysis of mitochondrial movement. Pixel
intensities in successive images were subtracted. A "movement
event" for each pixel was registered if the change in pixel fluorescence
between successive fields exceeded 20 fluorescence units; i.e., movement was
detected as an increase or decrease in individual pixel intensity over time.
The threshold value of 20 fluorescence units was determined empirically;
using a masking function in the SimplePCI software, mitochondria were found
to be well defined by pixels 20 U above background fluorescence. A
quantitative measure of mitochondrial movement was obtained by summating
movement events in a field over 2 min. Events were normalized by dividing the
pixel events per field by the total number of pixels occupied by mitochondria.
The analysis of mitochondrial movement described above was performed using
custom Visual Basic macros. Determination of mitochondrial length and
roundness was performed with a masking function in the SimplePCI software. The
degree of mitochondrial roundness was calculated using the measured area and
perimeter of identified objects and the following equation: roundness =
4
Area/
perimeter. Statistical comparisons between treatment groups
were performed using Student's unpaired t tests.
 |
Results
|
|---|
Mitochondrial size and movement
In this study we have made use of mt-eYFP to label neuronal mitochondria.
Using calcium phosphate we routinely obtained 1-2% transfection efficiency.
With this efficiency the density of transfected cells was such that typically
a single labeled cell was present per field, although sometimes additional
labeled processes traversed the field. The imaging conditions were optimized
to record individual mitochondria in processes, with the result that cell
bodies were usually overexposed. The limited extent of labeling provided
relatively simple images that were amenable to semi-automated image analysis.
Thus, we were able to determine the characteristics of mitochondrial length
quite readily (Fig. 1). Size
varied considerably, but the numerical majority of objects was relatively
small. This probably reflects the presence of bright, small mitochondria as
well as marginally labeled organelles with fluorescence intensity that did not
exceed threshold for the entire length of the organelle. The preponderance of
small objects in these images diminishes the impact of the modest number of
long mitochondria on the mean length, although the latter objects tend to
stand out on visual examination of the images.

View larger version (14K):
[in this window]
[in a new window]
|
Figure 1. Identification and measurement of mitochondrial length. A, A
fluorescence micrograph of a single cortical neuron transfected with
mitochondrially targeted eYFP (grayscale image). Selected groups of
mitochondria have been color coded to correspond to selected bins in the
frequency histogram below. B, Frequency distribution of mitochondrial
lengths. A representative frequency distribution derived from the above
micrograph. This figure is representative of 10 additional fields in which
mitochondrial length was determined.
|
|
We also used semi-automated approaches to estimate movement
(Fig. 2). To determine the
overall movement in a field, we used an approach that involves subtraction of
adjacent images of movies and then counted events that were defined as
bright-to-dark or dark-to-bright transitions of individual pixels that
exceeded an arbitrarily defined threshold. These events were summed over 2 min
of data acquisition (20 frames). Typically, this approach identified
5,000-20,000 events per 2 min period. In cells that had been fixed in
paraformaldehyde before imaging, the number of events detected in the same
time frame was typically <20, indicating that the noise associated with the
recording system did not make a meaningful contribution to this signal. This
method detects both directed movement of objects as well as lateral movement
of otherwise stationary objects ("wiggling"), although the latter
type of movement was quite limited in mitochondria constrained within
processes. We also tracked individual objects using the object tracking module
of Simple PCI to determine the velocity of the most rapidly moving objects
within fields. We visually identified individual objects from eight different
fields of cells on the basis of their rapid movement and estimated a mean
velocity of 0.63 ± 0.09 m/sec. These rapidly moving mitochondria were
inevitably small in length.

View larger version (33K):
[in this window]
[in a new window]
|
Figure 2. Measuring mitochondrial movement between two frames (see Materials and
Methods). A, Collected image field. A 255 x 255 pixel subregion
is selected for analysis. Individual pixel fluorescence values from successive
images (B, C) are subtracted. D, Threshold difference image.
Dark pixels indicate "events" where change in pixel fluorescence
exceeds a threshold value (20 fluorescence units). Pixel events for 20
successive images (2 min) were summated in each experiment.
|
|
Stimulus-induced alterations in size and movement
We next examined the effects of the mitochondrial uncoupler FCCP, which
rapidly dissipates the mitochondrial membrane potential. This can deplete
cellular ATP both by preventing its synthesis and also by consumption of ATP
by the F1FO ATPase. A 5 min application of FCCP promptly
decreased the movement of mitochondria without altering mitochondrial size
(Fig. 3). This suggests that
movement requires an adequate ATP supply, an intact mitochondrial membrane
potential, or possibly both; however, treatment with 10 µM
oligomycin produced a similar attenuation of mitochondrial movement
(Fig. 4C). This
suggests that local depletion of ATP and not changes in membrane potential may
impede the movement of mitochondria.

View larger version (11K):
[in this window]
[in a new window]
|
Figure 3. Effect of FCCP on mitochondrial movement and morphology. A, Mean
movement events per pixel measured after treatment with 750 nM
FCCP. B, Mean mitochondrial length after treatment of transfected
cells with 750 nM FCCP. *Significantly different from
control (p < 0.05; t test; control, n = 10;
FCCP, n = 7).
|
|

View larger version (50K):
[in this window]
[in a new window]
|
Figure 4. Glutamate induction of mitochondrial remodeling in cortical cultures. Shown
are representative micrographs of cortical neurons transfected with mt-eYFP,
before (A) and after (B) a 5 min treatment with 30
µM glutamate/1 µM glycine. C, Mean
measured mitochondrial movement after treatment of transfected neurons with 30
µM glutamate/1 µM glycine. Reductions in movement
after FCCP and oligomycin treatments are show for comparison.
*Significantly different from control (p < 0.05;
t test; No Treatment, n = 7; Glutamate, n = 5;
FCCP, n = 7; Oligomycin, n = 7). D, Representative
traces of mean mitochondrial length and roundness after treatment with
glutamate/glycine, derived from the image sequence shown in A and
B. Similar results were obtained in five additional fields of cells.
E, Pooled data of mitochondrial length measured after treatment with
glutamate/glycine. *Significantly different from control
(p < 0.05; t test; Control, n = 7; Glutamate,
n = 10). F, Mean mitochondrial roundness after
glutamate/glycine treatment. *Significantly different from control
(p < 0.05; t test; Control, n = 7; Glutamate,
n = 10).
|
|
Exposure of neurons to 30 µM glutamate with 1
µM glycine produced a somewhat different response. Although the
mitochondria clearly stopped moving within 2-4 min of glutamate application,
we also noted a profound alteration in mitochondrial morphology over the same
time frame (Fig. 4). Thus,
mitochondria that were initially thread-like in structure became notably
rounded. It is also possible that there was fragmentation, such that
individual thread-like objects became more than one rounded object; however,
it is difficult to conclusively establish that fragmentation explicitly occurs
rather than there being adjacent or overlapping objects that become
distinguishable when rounded. Although fragmentation may occur, it is not
clear that it would account for the majority of the morphological changes
evident in these images. Quantitation of the alteration in both movement and
length revealed that glutamate effectively decreased mitochondrial movement
and also produced a significant decrease in mitochondrial length
(Fig. 4). Sequential analysis
of length and object roundness during glutamate exposure indicated that the
decrease in length was associated with a simultaneous increase in
roundness.
Mechanisms underlying glutamate-induced morphological alteration
An evaluation of the mechanisms underlying this effect of glutamate
suggested a critical contribution of NMDA receptors. Applying glutamate in the
presence of MK801 (5 µM) completely blocked the effects of the
agonist, whereas the application of NMDA (100 µM with 1
µM glycine) also decreased mitochondrial length and diminished
movement. Interestingly, kainate (100 µM) did not mimic the
effects of glutamate. Given that kainate effectively depolarizes the plasma
membrane but results in a much smaller calcium load
(Stout and Reynolds, 1999
),
this observation suggested a key role for a substantial intracellular calcium
accumulation. Supporting this hypothesis, treatment of cultures with the
calcium ionophore 4-Br-A23187 (5 µM) produced the same effects
as glutamate on mitochondrial motility and morphology. Applying glutamate in a
calcium-free buffer also completely blocked the effect, indicating that the
remodeling was the consequence of NMDA receptor-mediated calcium entry and
presumably independent of either plasma membrane depolarization or
intracellular sodium accumulation.
We have shown previously that FCCP can protect neurons from glutamate
excitotoxicity, ostensibly as the result of preventing mitochondrial calcium
accumulation. Interestingly, applying glutamate in the presence of FCCP had no
impact on the calcium-dependent remodeling of mitochondrial shape
(Fig. 5). Under these
conditions there is unlikely to be a substantial accumulation of calcium in
the mitochondrial matrix, so this finding indicates that the probable locus of
action of calcium in this experiment is in the cytosol.

View larger version (96K):
[in this window]
[in a new window]
|
Figure 5. Glutamate-induced mitochondrial remodeling does not require mitochondrial
calcium uptake. Shown are representative micrographs of a neuron pretreated
(A) for 3 min with 750 nM FCCP and then superfused
(B) with 30 µM glutamate/1 µM glycine in
the continued presence of 750 nM FCCP.
|
|
Is the mitochondrial remodeling a consequence of dendrite
remodeling?
Previous studies have reported a prompt and reversible alteration in the
structure of the processes of cultured neurons in response to NMDA receptor
activation (Park et al., 1996
)
that shows a similar time course to the phenomenon observed here. To evaluate
the structure of the dendrites in comparison with the mitochondria, we
cotransfected cells with a cytosolic form of CFP along with mt-eYFP. A
parallel analysis of the two markers revealed that the mitochondrial
remodeling was accompanied by beading of dendrites, so that the structural
remodeling appears to occur concomitantly
(Fig. 6); however, mitochondria
do not appear to be specifically associated with either the swollen
varicosities or the narrowed parts of the process. This suggests that it is
unlikely that the remodeling is the consequence of the mitochondria
essentially being "pinched off" by the alteration in the structure
of the dendrite. It is also apparent that although the morphology of the
dendrites is clearly altered by glutamate treatment, they remain contiguous
rather than fragmented. This indicates that the rounded mitochondria do not
simply represent cellular debris at the end of a gross injury process. This
conclusion is reinforced by the studies on the recovery of normal morphology
described in the next section.

View larger version (47K):
[in this window]
[in a new window]
|
Figure 6. Comparison of mitochondrial and dendrite remodeling. A, Single
cortical neuron transfected with cytosolic eCFP. B, Effect of
perfusion on dendrite morphology after 5 min perfusion with 30
µM glutamate/1 µM glycine. C, Overlay of
fluorescence images of mt-eYFP and cytosolic ECFP before glutamate exposure.
D, Overlay image after superfusion with 30 µM
glutamate/1 µM glycine. Inset, Magnified region. These data are
representative of four additional fields.
|
|
Mitochondrial shape recovers after glutamate exposure
We next sought to determine whether mitochondrial shape recovered after
glutamate exposure. We assessed mitochondrial size 1 and 2 hr after glutamate
treatment. By 1 hr into the recovery period, the glutamate-treated neurons
were still clearly different from controls in that movement was limited and
the rounded mitochondria presented as the dominant phenotype. Interestingly,
however, neurons exposed to glutamate in the presence of FCCP showed a much
greater degree of recovery of morphology at this time point
(Fig. 7) and were
indistinguishable from controls. At longer time points (2 hr) but before frank
injury was apparent, both populations of treated cells had recovered to
control values. These data suggest that the FCCP co-treatment facilitated what
might be considered a normal recovery process.

View larger version (72K):
[in this window]
[in a new window]
|
Figure 7. Recovery of mitochondria after glutamate and combined FCCP + glutamate
treatments. Mitochondrial length was measured immediately after treatment of
transfected cells with 30 µM glutamate/1 µM
glycine and subsequently measured 1 and 2 hr after treatment.
*Significantly different from control (p < 0.05;
t test; n ranges between 7 and 15 for each bar).
|
|
 |
Discussion
|
|---|
The main findings of this study are that glutamate, as a consequence of
NMDA receptor activation, produces a rapid and substantial remodeling of
mitochondrial morphology and also causes a cessation of mitochondrial
movement. These previously unappreciated aspects of the action of glutamate at
concentrations just sufficient to cause excitotoxic injury suggest that there
may be effects of glutamate on mitochondria that extend beyond the
bioenergetic and ROS generation effects that we and other laboratories have
documented previously. In particular, these findings suggest that neuronal
injury might alter the trafficking of mitochondria to cellular destinations
where ATP synthesis is required and thus impair cellular function.
There is an emerging appreciation that mitochondrial morphology is a
dynamic parameter that may be associated with cell injury. In several
different models of apoptosis it has been reported that the normal
mitochondrial reticulum becomes fragmented after the application of apoptotic
stimuli (Desagher and Martinou,
2000
; Frank et al.,
2001
). Fragmentation of mitochondria may be a consequence of the
association of proteins such as dynamin-related protein 1 (DRP1) with
mitochondria. Overexpression of this protein causes fragmentation
(Frank et al., 2001
;
Filiano et al., 2002
), whereas
a dominant-negative form of DRP1 decreases sensitivity to mitochondrially
mediated apoptosis (Frank et al.,
2001
). It is not clear whether such mechanisms are activated by
calcium, or even whether DRP1 is normally present in neurons. A different
family of proteins appears to mediate fusion of mitochondria
(Santel and Fuller, 2001
). It
is also possible that an inhibition of an ongoing fusion reaction could result
in an apparent fragmentation or rounding, although there is no precedent for
this kind of effect as far as we are aware.
Alterations in mitochondrial morphology in both neurons and astrocytes in
response to calcium loading has also been reported by Dubinsky and colleagues
(Kristal and Dubinsky, 1997
;
Dubinsky and Levi, 1998
), who
also found that mitochondria changed from a rod-like to spherical morphology
when challenged. In these studies the authors concluded that the shape change
was caused by mitochondrial permeability transition. Our preliminary
experiments indicated that the classic transition inhibitor cyclosporin A was
ineffective in preventing these morphological changes (data not shown). There
is also the ambiguity in these studies that the shape change was detected with
a membrane potential-sensitive dye under conditions in which the membrane
potential is clearly a variable (Schinder
et al., 1996
; White and
Reynolds, 1996
; Duchen et al.,
1998
). Nevertheless, our findings clearly support the
morphological conclusions in these earlier reports. The consequence of the
alteration in morphology for mitochondrial function is much less clear. It has
been proposed that the elongated or reticulated form of mitochondria is
beneficial on the basis of studies in cardiac myocytes
(Amchenkova et al., 1988
).
Thus, because of the cable properties of mitochondria, the proton motive force
generated by the electron transport chain can be effectively distributed
across the reticulum and thus facilitate ATP synthesis. This advantage is
hypothetical at this point, however, because it remains unclear whether the
ability of mitochondria to generate a proton motive force is spatially
limited. Because both FCCP or an excessive calcium load result in
mitochondrial depolarization in our experiments, it is difficult to assess
mitochondrial function in mitochondria after rounding, so we cannot readily
establish whether function is modified as a direct consequence of the shape
change.
A second dramatic consequence of the action of glutamate is the cessation
of mitochondrial movement. The directional movement of mitochondria in neurons
is accomplished using the microtubule network and can be inhibited by
stabilizing microtubules with drugs like nocodazole
(Morris and Hollenbeck, 1995
;
Overly et al., 1996
;
Ligon and Steward, 2000b
).
Movement on the actin cytoskeleton has also been reported
(Morris and Hollenbeck, 1995
).
Movement is presumably driven by motor proteins such as kinesin and dynein
(Goldstein, 2001
) as well as
myosin (Morris and Hollenbeck,
1995
), although the specific interactions governing this mechanism
in the context of neuronal mitochondria have not been clearly established. The
cytoskeleton is clearly subject to profound alterations in the face of a
robust calcium load. The actin cytoskeleton can be modified by
calcium-mediated activation of gelsolin, whereas calcineurin activation
results in dephosphorylation of microtubule-associated proteins
(van Rossum and Hanisch,
1999
). Fodrin is a substrate for calpains, which may also be
activated under these circumstances (van
Rossum and Hanisch, 1999
), although we have found that calpain
inhibitors do not prevent this effect of glutamate (data not shown). Thus,
there are many factors that could alter the substrates on which mitochondria
move. Movement is also an ATP-dependent process, and the depolarization of
mitochondria combined with the potential impairment of function associated
with the calcium load could deplete local ATP concentrations quite rapidly.
Thus, a number of different mechanisms could contribute to the cessation of
movement. The mechanisms responsible for the alteration in movement may also
underlie the shape change. If the rod-like structure associated with normal
mitochondria is essentially a function of the organelle being stretched out on
a cytoskeletal structure, the dissolution of that structure could result in
the rounding that we observe.
It is interesting to consider the role that these glutamate-mediated
effects on mitochondria might have in the expression of excitotoxic injury.
The effects are clearly produced by concentrations and exposure times of
glutamate that are around the threshold for neuronal injury; however, the
changes in shape and movement that we observe are the same in the presence and
absence of FCCP. This is notable, because we have demonstrated previously that
the combined application of FCCP with glutamate protects neurons from
excitotoxic injury, ostensibly as the result of preventing mitochondrial
calcium accumulation (Stout et al.,
1998
). Because both rounding and movement cessation occur in the
presence of FCCP with glutamate, one can conclude that rounding of
mitochondria or their temporary immobilization does not inevitably lead to
injury; however, it is interesting to note that the presence of FCCP during
glutamate exposure clearly facilitates the recovery of the normal
morphological phenotype. This suggests that the protection of mitochondrial
function (by preventing calcium overload) aids in the restoration of
mitochondria to their normal state. Thus, in this experimental paradigm, the
alteration of mitochondrial morphology would be considered a symptom rather
than a cause of cell injury. Indeed, this raises the possibility that either
the shape or movement change could be an attempt to protect the cell from
injury, although what exactly is accomplished by this maneuver remains to be
established.
More broadly, these experiments clearly establish an unappreciated dynamic
that exists between the distribution of mitochondria within cells and their
bioenergetic status. Under conditions of less acute injury mechanisms, one
might anticipate that impaired mitochondrial function would alter the ability
of mitochondria to move and thereby prevent the normal distribution of
mitochondria within neurons. Under conditions of chronic stress, this could
stop new mitochondria from being delivered to distal parts of the neuron or
possibly even prevent the retrieval of dysfunctional mitochondria to the cell
body for degradation, either of which may result in cell damage. When one
considers the number of endogenous toxins (such as zinc, nitric oxide, and
oxidative stress) as well as xenobiotics (such as MPTP, rotenone,
3-nitroproprionic acid), that impair mitochondrial function and dissipate the
mitochondrial membrane potential, it seems likely that the alteration of the
trafficking and morphology of mitochondria is likely to be a broadly important
phenomenon associated with neuronal injury.
 |
Footnotes
|
|---|
Received Feb 24, 2003;
revised June 23, 2003;
accepted July 2, 2003.
These studies were supported by U.S. Army Medical Research and Materiel
Command Neurotoxin Research Initiative Grant DAMD 17-98-1-8269 (I.J.R.) and
Human Frontiers Science Program Grant LT0500/1999/B (J.B.B.). We thank Dr.
Roger Y. Tsien for providing the mt-eYFP construct.
Correspondence should be addressed to Ian J. Reynolds, Department of
Pharmacology, University of Pittsburgh, W1351 Biomedical Science Tower,
Pittsburgh PA 15261. E-mail:
iannmda{at}pitt.edu.
J. B. Brocard's present address: Département de Réponse et de
Dynamique Cellularies, laboratoire Canaux Ioniques et Signalisation, 38054
Grenoble Cedex, France.
Copyright © 2003 Society for Neuroscience
0270-6474/03/237881-08$15.00/0
 |
References
|
|---|
Amchenkova AA, Bakeeva LE, Chentsov YS, Skulachev VP, Zorov DB
(1988) Coupling membranes as energy-transmitting cables. I.
Filamentous mitochondria in fibroblasts and mitochondrial clusters in
cardiomyocytes. J Cell Biol 107:
481-492.[Abstract/Free Full Text]
Beal MF (2000) Energetics in the pathogenesis of
neurodegenerative diseases. Trends Neurosci
23: 298-304.[Web of Science][Medline]
Buckman JF, Reynolds IJ (2001) Spontaneous changes in
mitochondrial membrane potential in cultured neurons. J
Neurosci 21:
5054-5065.[Abstract/Free Full Text]
Budd SL, Nicholls DG (1996) Mitochondria, calcium
regulation and acute glutamate excitotoxicity in cultured cerebellar granule
cells. J Neurochem 67:
2282-2291.[Web of Science][Medline]
Davis AF, Clayton DA (1996) In situ localization of
mitochondrial DNA replication in intact mammalian cells. J Cell
Biol 135:
883-893.[Abstract/Free Full Text]
Desagher S, Martinou JC (2000) Mitochondria as the
central control point of apoptosis. Trends Cell Biol
10: 369-377.[Web of Science][Medline]
Djaldetti M (1982) Mitochondrial abnormalities in the
cells of myeloma patients. Acta Haematologica
68: 241-248.[Web of Science][Medline]
Dubinsky JM, Levi Y (1998) Calcium induced activation
of the mitochondrial permeability transition in hippocampal neurons. J
Neurosci Res 53:
728-741.[Web of Science][Medline]
Duchen MR, Leyssens A, Crompton M (1998) Transient
mitochondrial depolarizations reflect focal sarcoplasmic reticular calcium
release in single rat cardiomyocytes. J Cell Biol
142: 975-988.[Abstract/Free Full Text]
Dugan LL, Sensi SL, Canzoniero LMT, Handran SD, Rothman SM, Lin
T-S, Goldberg MP, Choi DW (1995) Mitochondrial production of
reactive oxygen species in cortical neurons after exposure to NMDA. J
Neurosci 15:
6377-6388.[Abstract/Free Full Text]
Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B,
Mandelkow E (1998) Overexpression of tau protein inhibits
kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic
reticulum: implications for Alzheimer's disease. J Cell Biol
143: 777-794.[Abstract/Free Full Text]
Filiano AJ, Rintoul GL, Brocard JB, Votyakova TV, Reynolds IJ
(2002) Mitochondrial homeostasis and neuronal injury in primary
cortical cultures. Soc Neurosci Abstr
32: 297.2.
Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez
F, Smith CL, Youle RJ (2001) The role of dynamin-related protein
1, a mediator of mitochondrial fission, in apoptosis. Dev Cell
1: 515-525.[Web of Science][Medline]
Goldstein LS (2001) Molecular motors: from one motor
many tails to one motor many tales. Trends Cell Biol
11: 477-482.[Web of Science][Medline]
Heales SJ, Bolaños JP, Stewart VC, Brookes PS, Land JM,
Clark JB (1999) Nitric oxide, mitochondria and neurological
disease. Biochim Biophys Acta 1410:
215-228.[Medline]
Jouaville LS, Pinton P, Bastianutto C, Rutter GA, Rizzuto R
(1999) Regulation of mitochondrial ATP synthesis by calcium:
evidence for long term metabolic priming. Proc Natl Acad Sci
USA 96:
13807-13812.[Abstract/Free Full Text]
Kress GJ, Dineley KE, Reynolds IJ (2002) The
relationship between intracellular free iron and cell injury in cultured
neurons, astrocytes, and oligodendrocytes. J Neurosci
22: 5848-5855.[Abstract/Free Full Text]
Kristal BS, Dubinsky JM (1997) Mitochondrial
permeability transition in the central nervous system: induction by calcium
cycling-dependent and independent pathways. J Neurochem
69: 524-538.[Web of Science][Medline]
Ligon LA, Steward O (2000a) Movement of mitochondria
in the axons and dendrites of cultured hippocampal neurons. J Comp
Neurol 347:
340-350.
Ligon LA, Steward O (2000b) Role of microtubules and
actin filaments in the movement of mitochondria in the axons and dendrites of
cultured hippocampal neurons. J Comp Neurol
427: 351-361.[Web of Science][Medline]
Llopis J, McCaffery JM, Miyawaki A, Farquhar MG, Tsien RY
(1998) Measurement of cytosolic, mitochondrial and Golgi pH in
single living cells with green fluorescent proteins. Proc Natl Acad Sci
USA 95:
6803-6808.[Abstract/Free Full Text]
Morris RL, Hollenbeck PJ (1993) The regulation of
bidirectional mitochondrial transport is coordinated with axonal outgrowth.
J Cell Sci 104:
917-927.[Abstract]
Morris RL, Hollenbeck PJ (1995) Axonal transport of
mitochondria along microtubules and F-actin in living vertebrate neurons.
J Cell Biol 131:
1315-1326.[Abstract/Free Full Text]
Nicholls DG, Budd SL (2000) Mitochondria and neuronal
survival. Physiol Rev 80:
315-360.[Abstract/Free Full Text]
Nishino I, Kobayashi O, Goto Y, Kurihara M, Kumagai K, Fujita T,
Hashimoto K, Horai S, Nonaka I (1998) A new congenital muscular
dystrophy with mitochondrial structural abnormalities. Muscle
Nerve 21:
40-47.[Web of Science][Medline]
Overly CC, Rieff HI, Hollenbeck PJ (1996) Organelle
motility and metabolism in axons vs dendrites of cultured hippocampal neurons.
J Cell Sci 109:
971-980.[Abstract]
Park JS, Bateman MC, Goldberg MP (1996) Rapid
alterations in dendrite morphology during sublethal hypoxia or glutamate
receptor activation. Neurobiol Dis 3:
215-227.[Web of Science][Medline]
Reynolds IJ, Hastings TG (1995) Glutamate induces the
production of reactive oxygen species in cultured forebrain neurons following
NMDA receptor activation. J Neurosci 15:
3318-3327.[Abstract]
Rintoul GL, Filiano AJ, Brocard JB, Werner D, Reynolds IJ
(2002) Mitochondrial remodeling in response to excitotoxic
glutamate treatment of primary cortical cultures. Soc Neurosci
Abstr 32:
297.1.
Santel A, Fuller MT (2001) Control of mitochondrial
morphology by a human mitofusin. J Cell Sci
114: 867-874.[Abstract]
Schapira AH (1999) Mitochondrial involvement in
Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and
Friedreich's ataxia. Biochim Biophys Acta
1410: 159-170.[Medline]
Scheffler IE (1999) Mitochondria. New
York: Wiley.
Schinder AF, Olson EC, Spitzer NC, Montal M (1996)
Mitochondrial dysfunction is a primary event in glutamate neurotoxicity.
J Neurosci 16:
6125-6133.[Abstract/Free Full Text]
Stout AK, Reynolds IJ (1999) High-affinity calcium
indicators underestimate increases in intracellular calcium concentrations
associated with excitotoxic glutamate stimulations.
Neuroscience 89:
91-100.[Web of Science][Medline]
Stout AK, Raphael HM, Kanterewicz BI, Klann E, Reynolds IJ
(1998) Glutamate-induced neuron death requires mitochondrial
calcium uptake. Nat Neurosci 1:
366-373.[Web of Science][Medline]
Tandler B, Hoppel CL (1986) Studies on giant
mitochondria. Ann NY Acad Sci 488:
65-81.[Web of Science][Medline]
van Rossum D, Hanisch UK (1999) Cytoskeletal dynamics
in dendritic spines: direct modulation by glutamate receptors? Trends
Neurosci 22:
290-295.[Web of Science][Medline]
Weiss JH, Sensi SL, Koh JY (2000) Zn(2+): a novel
ionic mediator of neural injury in brain disease. Trends Pharmacol
Sci 21:
395-401.[Medline]
White RJ, Reynolds IJ (1995) Mitochondria and
Na+/Ca2+ exchange buffer glutamate-induced calcium loads
in cultured cortical neurons. J Neurosci
15: 1318-1328.[Abstract]
White RJ, Reynolds IJ (1996) Mitochondrial
depolarization in glutamate-stimulated neurons: an early signal specific to
excitotoxin exposure. J Neurosci 16:
5688-5697.[Abstract/Free Full Text]
Xia Z, Dudek H, Miranti CK, Greenberg ME (1996)
Calcium influx via the NMDA receptor induces immediate early gene
transcription by a MAP kinase/ERK-dependent mechanism. J
Neurosci 16:
5425-5436.[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
R. A. Quintanilla, T. A. Matthews-Roberson, P. J. Dolan, and G. V. W. Johnson
Caspase-cleaved Tau Expression Induces Mitochondrial Dysfunction in Immortalized Cortical Neurons: IMPLICATIONS FOR THE PATHOGENESIS OF ALZHEIMER DISEASE
J. Biol. Chem.,
July 10, 2009;
284(28):
18754 - 18766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Saotome, D. Safiulina, G. Szabadkai, S. Das, A. Fransson, P. Aspenstrom, R. Rizzuto, and G. Hajnoczky
Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase
PNAS,
December 30, 2008;
105(52):
20728 - 20733.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kitayama, Y. Miura, Y. Ando, S. Hoshino, Y. Ishizaka, and Y. Koyanagi
Human Immunodeficiency Virus Type 1 Vpr Inhibits Axonal Outgrowth through Induction of Mitochondrial Dysfunction
J. Virol.,
March 1, 2008;
82(5):
2528 - 2542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Zhdanov, M. W. Ward, J. H. M. Prehn, and D. B. Papkovsky
Dynamics of Intracellular Oxygen in PC12 Cells upon Stimulation of Neurotransmission
J. Biol. Chem.,
February 29, 2008;
283(9):
5650 - 5661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Baloh
Mitochondrial Dynamics and Peripheral Neuropathy
Neuroscientist,
February 1, 2008;
14(1):
12 - 18.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kaasik, D. Safiulina, V. Choubey, M. Kuum, A. Zharkovsky, and V. Veksler
Mitochondrial Swelling Impairs the Transport of Organelles in Cerebellar Granule Neurons
J. Biol. Chem.,
November 9, 2007;
282(45):
32821 - 32826.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Greenwood, S. M. Mizielinska, B. G. Frenguelli, J. Harvey, and C. N. Connolly
Mitochondrial Dysfunction and Dendritic Beading during Neuronal Toxicity
J. Biol. Chem.,
September 7, 2007;
282(36):
26235 - 26244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Jahani-Asl, E. C. C. Cheung, M. Neuspiel, J. G. MacLaurin, A. Fortin, D. S. Park, H. M. McBride, and R. S. Slack
Mitofusin 2 Protects Cerebellar Granule Neurons against Injury-induced Cell Death
J. Biol. Chem.,
August 17, 2007;
282(33):
23788 - 23798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Kann and R. Kovacs
Mitochondria and neuronal activity
Am J Physiol Cell Physiol,
February 1, 2007;
292(2):
C641 - C657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kaasik, D. Safiulina, A. Zharkovsky, and V. Veksler
Regulation of mitochondrial matrix volume
Am J Physiol Cell Physiol,
January 1, 2007;
292(1):
C157 - C163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Chandrasekaran, J. L. Hazelton, Y. Wang, G. Fiskum, and T. Kristian
Neuron-Specific Conditional Expression of a Mitochondrially Targeted Fluorescent Protein in Mice
J. Neurosci.,
December 20, 2006;
26(51):
13123 - 13127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Shalbuyeva, T. Brustovetsky, A. Bolshakov, and N. Brustovetsky
Calcium-dependent Spontaneously Reversible Remodeling of Brain Mitochondria
J. Biol. Chem.,
December 8, 2006;
281(49):
37547 - 37558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Beltran-Parrazal, H. E. Lopez-Valdes, K. C. Brennan, M. Diaz-Munoz, J. de Vellis, and A. C. Charles
Mitochondrial transport in processes of cortical neurons is independent of intracellular calcium
Am J Physiol Cell Physiol,
December 1, 2006;
291(6):
C1193 - C1197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T. W. Chang, A. S. Honick, and I. J. Reynolds
Mitochondrial trafficking to synapses in cultured primary cortical neurons.
J. Neurosci.,
June 28, 2006;
26(26):
7035 - 7045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Nicholls
Simultaneous Monitoring of Ionophore- and Inhibitor-mediated Plasma and Mitochondrial Membrane Potential Changes in Cultured Neurons
J. Biol. Chem.,
May 26, 2006;
281(21):
14864 - 14874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. E. Glater, L. J. Megeath, R. S. Stowers, and T. L. Schwarz
Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent
J. Cell Biol.,
May 22, 2006;
173(4):
545 - 557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Hollenbeck and W. M. Saxton
The axonal transport of mitochondria
J. Cell Sci.,
December 1, 2005;
118(23):
5411 - 5419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Malaiyandi, A. S. Honick, G. L. Rintoul, Q. J. Wang, and I. J. Reynolds
Zn2+ Inhibits Mitochondrial Movement in Neurons by Phosphatidylinositol 3-Kinase Activation
J. Neurosci.,
October 12, 2005;
25(41):
9507 - 9514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kovacs, J. Kardos, U. Heinemann, and O. Kann
Mitochondrial Calcium Ion and Membrane Potential Transients Follow the Pattern of Epileptiform Discharges in Hippocampal Slice Cultures
J. Neurosci.,
April 27, 2005;
25(17):
4260 - 4269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Darios, M.-P. Muriel, M. E. Khondiker, A. Brice, and M. Ruberg
Neurotoxic Calcium Transfer from Endoplasmic Reticulum to Mitochondria Is Regulated by Cyclin-Dependent Kinase 5-Dependent Phosphorylation of Tau
J. Neurosci.,
April 20, 2005;
25(16):
4159 - 4168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yi, D. Weaver, and G. Hajnoczky
Control of mitochondrial motility and distribution by the calcium signal: a homeostatic circuit
J. Cell Biol.,
November 22, 2004;
167(4):
661 - 672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. Reynolds and G. L. Rintoul
Mitochondrial Stop and Go: Signals That Regulate Organelle Movement
Sci. Signal.,
September 21, 2004;
2004(251):
pe46 - pe46.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Jekabsons and D. G. Nicholls
In Situ Respiration and Bioenergetic Status of Mitochondria in Primary Cerebellar Granule Neuronal Cultures Exposed Continuously to Glutamate
J. Biol. Chem.,
July 30, 2004;
279(31):
32989 - 33000.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. B. Pivovarova, H. V. Nguyen, C. A. Winters, C. A. Brantner, C. L. Smith, and S. B. Andrews
Excitotoxic Calcium Overload in a Subpopulation of Mitochondria Triggers Delayed Death in Hippocampal Neurons
J. Neurosci.,
June 16, 2004;
24(24):
5611 - 5622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Alano, W. Ying, and R. A. Swanson
Poly(ADP-ribose) Polymerase-1-mediated Cell Death in Astrocytes Requires NAD+ Depletion and Mitochondrial Permeability Transition
J. Biol. Chem.,
April 30, 2004;
279(18):
18895 - 18902.
[Abstract]
[Full Text]
[PDF]
|
 |
|